Related references
Note: Only part of the references are listed.Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure
Maureen J. Kimulwo et al.
PLOS ONE (2017)
Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study
Margaret Ngwono Oluka et al.
AIDS RESEARCH AND THERAPY (2015)
Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations
Aparna Mukherjee et al.
INDIAN PEDIATRICS (2014)
The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy
Yuncong Wang et al.
AIDS RESEARCH AND THERAPY (2014)
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
Quirine Fillekes et al.
AIDS (2013)
Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study
Alexander Zoufaly et al.
ANTIVIRAL THERAPY (2013)
Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience
Mina Nikanjam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naive perinatally-infected children and adolescents with HIV-1 subtype C infection
Ujjwal Neogi et al.
BMC INFECTIOUS DISEASES (2012)
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices
Andrea Calcagno et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Standing Genetic Variation and the Evolution of Drug Resistance in HIV
Pleuni Simone Pennings
PLOS COMPUTATIONAL BIOLOGY (2012)
Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory
Ekta Varshney et al.
SPRINGERPLUS (2012)
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
Kulkanya Chokephaibulkit et al.
ANTIVIRAL THERAPY (2011)
Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India
Soumya Swaminathan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children
Amanda H. Corbett et al.
ANTIVIRAL THERAPY (2010)
Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 (R) tablets
Goenke Poerksen et al.
ANTIVIRAL THERAPY (2010)
Strategies for Nevirapine Initiation in HIV-Infected Children Taking Pediatric Fixed-Dose Combination Baby Pills in Zambia: A Randomized Controlled Trial
V. Mulenga et al.
CLINICAL INFECTIOUS DISEASES (2010)
Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study
Weerawat Manosuthi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
A Chewable Pediatric Fixed-dose Combination Tablet of Stavudine, Lamivudine, and Nevirapine Pharmacokinetics and Safety Compared With the Individual Liquid Formulations in Human Immunodeficiency Virus-infected Children in Thailand
Nirun Vanprapar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Pharmacokinetic Assessment of Nevirapine and Metabolites in Human Immunodeficiency Virus Type 1-Infected Patients with Hepatic Fibrosis
Anna Maria Cammett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
Geetha Ramachandran et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Assessment of Adherence to Antiretroviral Therapy in Perinatally HIV-Infected Children and Youth Using Self-Report Measures and Pill Count
John J. Farley et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2008)
Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children
Marie-Laure Chaix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasma
Geetha Ramachandran et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu et al.
CLINICAL INFECTIOUS DISEASES (2006)
Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study
Esse N. Menson et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Nevirapine plasma exposure affects both durability of viral suppression and selection of Nevirapine primary resistance mutations in a clinical setting
DG de Requena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Practical guidelines to interpret plasma concentrations of antiretroviral drugs
BS Kappelhoff et al.
CLINICAL PHARMACOKINETICS (2004)
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients
JO Stern et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population
TEMS de Vries-Sluijs et al.
CLINICAL PHARMACOKINETICS (2003)
Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
MMR de Maat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
AI Veldkamp et al.
AIDS (2001)
Nevirapine - Pharmacokinetic considerations in children and pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2000)
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
P Barreiro et al.
AIDS (2000)
Share Paper
